#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16538	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2635	774.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1712	1712	C	1050	C,T	1047,3	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	847.7	0	.	n	.	0	T695C	SNP	695	695	T	1416	1416	C	1054	C	1054	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	847.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	2058	2058	A	1192	A,G	1191,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	847.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2692	2692	C	979	C,T,A	977,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	847.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2766	2766	A	901	A	901	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4203	847.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3318	3318	C	1057	C,T,G	1055,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2394	folP	855	855	99.88	folP.l6.c4.ctg.1	2091	142.7	1	SNP	p	R229S	1	.	.	685	687	AGC	1304	1306	AGC	246;245;248	A;G;C,T	245;245;247,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3946	166.4	1	SNP	p	S91F	1	.	.	271	273	TTC	851	853	TTC	177;180;179	T;T;C	177;180;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3946	166.4	1	SNP	p	D95G	1	.	.	283	285	GGC	863	865	GGC	196;198;199	G;G,C,A;C	196;196,1,1;199	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5260	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3946	166.4	1	SNP	p	G95N	0	.	.	283	285	GGC	863	865	GGC	196;198;199	G;G,C,A;C	196;196,1,1;199	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	2046	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1848	138.2	1	SNP	p	G45D	0	.	.	133	135	GGC	693	695	GGC	240;241;243	G;G;C,T,A	240;241;241,1,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1098	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1594	85.9	0	.	n	.	0	A197.	DEL	197	197	A	800	800	A	192	A	192	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3647	180.5	1	SNP	p	D86N	0	.	.	256	258	GAC	943	945	GAC	219;221;221	G;A,G;C	219;219,2;221	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3647	180.5	1	SNP	p	S87R	1	.	.	259	261	CGT	946	948	CGT	221;223;221	C;G;T,G	221;223;220,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3647	180.5	1	SNP	p	R87W	0	.	.	259	261	CGT	946	948	CGT	221;223;221	C;G;T,G	221;223;220,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3647	180.5	1	SNP	p	R87I	0	.	.	259	261	CGT	946	948	CGT	221;223;221	C;G;T,G	221;223;220,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5272	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3647	180.5	1	SNP	p	S88P	0	.	.	262	264	TCC	949	951	TCC	221;225;227	T;C;C	221;225;227	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4408	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3141	175.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1797	1799	GGC	261;258;257	G,T;G,C;C	260,1;257,1;257	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1587	1589	GCA	255;254;258	G;C;A	255;254;258	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1590	1592	ATC	261;260;259	A;T,C;C	261;259,1;259	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1602	1604	GTG	257;259;261	G;T;G	257;259;261	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1602	1604	GTG	257;259;261	G;T;G	257;259;261	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2106	2108	ACC	246;248;249	A,G;C,G;C	245,1;247,1;249	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2160	2162	GCG	248;244;245	G;C;G	248;244;245	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2160	2162	GCG	248;244;245	G;C;G	248;244;245	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2283	2285	AGC	216;218;216	A;G;C	216;218;216	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2292	2294	GGC	219;219;219	G;G;C	219;219;219	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4330	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2961	182.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2310	2312	CCG	232;237;238	C,G;C;G,C	230,1;236;237,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5984	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3641	205.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1952	1954	CCG	241;242;239	C;C;G,A,C	241;242;237,1,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2368	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2270	130.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	791	791	C	165	C	165	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	156	92.95	porB1a.l15.c30.ctg.1	156	61.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	32;35;36	T;T;A	32;35;36	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	156	92.95	porB1a.l15.c30.ctg.1	156	61.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	77;77;77	C;A;T	77;77;77	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	156	92.95	porB1a.l15.c30.ctg.1	156	61.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	77;77;77	A;G;T	77;77;77	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	338	porB1a	984	156	92.95	porB1a.l15.c30.ctg.1	156	61.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	77;77;77	T;A;C	77;77;77	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3216	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1800	220.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1075	1075	T	268	T,A	267,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3216	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1800	220.7	1	SNP	p	G120K	0	.	.	358	360	GGT	802	804	GGT	255;256;256	G;G;T	255;256;256	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3216	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1800	220.7	1	SNP	p	A121N	0	.	.	361	363	GCC	805	807	GCC	254;255;255	G;C;C,A	254;255;254,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3216	porB1b	1035	1035	98.66	porB1b.l15.c17.ctg.1	1800	220.7	1	SNP	p	A121D	0	.	.	361	363	GCC	805	807	GCC	254;255;255	G;C;C,A	254;255;254,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11162	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5370	259.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1558	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1678	115.9	1	SNP	p	V57M	1	.	.	169	171	ATG	814	816	ATG	247;246;243	A,T;T,C;GAA,GA	246,1;243,3;236,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
